Journal article
Treatment of advanced and recurrent gynecologic cancer
Cancer, v 60(S8), pp 2081-2093
15 Oct 1987
PMID: 3308068
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
In 1986 73,400 new cases of invasive gynecologic cancer and 45,000 new cases of in situ carcinoma of the uterine cervix (about 9% of all cancers in women) were diagnosed in the US. A significant proportion of these patients die of local failure. In dealing with the wide variety of gynecologic cancers, extreme care must be used in choosing the appropriate treatment program for each problem. Therefore, the full extent of the disease at the time of initial presentation and recurrence must be determined. It is only with these data that appropriate treatment programs can be designed with the maximum potential for long‐term control or cure and with the minimum in treatment complication. There are no groups of disease processes like those seen in advanced or recurrent gynecologic cancer that offer such a challenge to the clinical practitioner.
Metrics
Details
- Title
- Treatment of advanced and recurrent gynecologic cancer
- Creators
- Luther W. Brady - Hahnemann University HospitalArnold M. Markoe - Hahnemann University HospitalTimothy Deeulis - Pennsylvania HospitalGeorge C. Lewis - Thomas Jefferson University
- Publication Details
- Cancer, v 60(S8), pp 2081-2093
- Publisher
- Wiley Subscription Services, Inc., A Wiley Company
- Number of pages
- 13
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Web of Science ID
- WOS:A1987K299800021
- Scopus ID
- 2-s2.0-0023231682
- Other Identifier
- 991019184078804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology